About HGHVX
The Hartford Healthcare Fund Class R6 is an actively managed mutual fund dedicated to investments in the global healthcare sector. Its primary objective is to achieve long-term capital appreciation by allocating at least 80% of its assets to equity securities of healthcare-related companies across the world. The fund targets a broad spectrum of businesses within the sector, including those involved in pharmaceuticals, biotechnology, medical devices, medical services, and healthcare technology. Managed by Hartford Mutual Funds with sub-advisory from Wellington Management Company, the fund leverages in-depth research to identify firms poised to benefit from demographic changes, globalization, and innovation within healthcare.
With a diverse portfolio typically consisting of around 100 holdings, the fund invests mainly in large-capitalization companies, though it maintains exposure across various market caps. The Class R6 share structure is tailored for institutional investors, offering a competitive expense ratio and no minimum investment requirement. By focusing globally and embracing healthcare’s dynamic landscape, the Hartford Healthcare Fund Class R6 plays a specialized role in investor portfolios seeking to capitalize on long-term trends in health and life sciences, as measured against benchmarks like the S&P Composite 1500 Health Care Index.
Fund Family Hartford Mutual Funds
Category Health
Performance Rating Average
Risk Rating Average
Stock Exchange Nasdaq
Ticker Symbol HGHVX
Share Class Class R6
Index S&P Composite 1500 Health Care TR
HGHVX had a total return of 19.26% in the past year, including dividends. Since the fund's
inception, the average annual return has been 8.86%.
